JLB & Associates Inc. Sells 120 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

JLB & Associates Inc. cut its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 6.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,630 shares of the medical instruments supplier’s stock after selling 120 shares during the period. JLB & Associates Inc.’s holdings in Mettler-Toledo International were worth $1,995,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Suncoast Equity Management raised its holdings in shares of Mettler-Toledo International by 10.7% in the 4th quarter. Suncoast Equity Management now owns 509 shares of the medical instruments supplier’s stock worth $623,000 after buying an additional 49 shares in the last quarter. Boston Financial Mangement LLC boosted its holdings in Mettler-Toledo International by 12.8% in the fourth quarter. Boston Financial Mangement LLC now owns 7,429 shares of the medical instruments supplier’s stock valued at $9,091,000 after acquiring an additional 843 shares during the last quarter. Handelsbanken Fonder AB boosted its stake in shares of Mettler-Toledo International by 14.3% in the 4th quarter. Handelsbanken Fonder AB now owns 12,913 shares of the medical instruments supplier’s stock valued at $15,801,000 after purchasing an additional 1,618 shares during the last quarter. Truist Financial Corp grew its holdings in Mettler-Toledo International by 1.3% during the 4th quarter. Truist Financial Corp now owns 1,053 shares of the medical instruments supplier’s stock worth $1,289,000 after acquiring an additional 14 shares during the period. Finally, CIBC Asset Management Inc grew its stake in shares of Mettler-Toledo International by 4.1% during the fourth quarter. CIBC Asset Management Inc now owns 3,235 shares of the medical instruments supplier’s stock worth $3,959,000 after purchasing an additional 128 shares during the period. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Stock Performance

Shares of MTD opened at $1,302.24 on Friday. The stock has a market capitalization of $27.24 billion, a price-to-earnings ratio of 32.13, a PEG ratio of 3.30 and a beta of 1.13. Mettler-Toledo International Inc. has a 52 week low of $1,142.91 and a 52 week high of $1,546.93. The stock has a fifty day moving average of $1,284.88 and a 200-day moving average of $1,334.32.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. As a group, equities analysts forecast that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Insider Transactions at Mettler-Toledo International

In related news, insider Gerry Keller sold 140 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the sale, the insider now owns 6 shares in the company, valued at $7,524.54. This represents a 95.89 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.94% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Stifel Nicolaus lowered their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research note on Monday, November 11th. Wolfe Research assumed coverage on shares of Mettler-Toledo International in a report on Friday, December 13th. They set a “peer perform” rating on the stock. Robert W. Baird boosted their price objective on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Evercore ISI upped their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research note on Monday, February 10th. Finally, Wells Fargo & Company lifted their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a report on Monday, February 10th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $1,368.00.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.